DK0489379T3 - 5-Amino-5,6,7,8-tetrahydroquinoliner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendels - Google Patents
5-Amino-5,6,7,8-tetrahydroquinoliner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelsInfo
- Publication number
- DK0489379T3 DK0489379T3 DK91120652T DK91120652T DK0489379T3 DK 0489379 T3 DK0489379 T3 DK 0489379T3 DK 91120652 T DK91120652 T DK 91120652T DK 91120652 T DK91120652 T DK 91120652T DK 0489379 T3 DK0489379 T3 DK 0489379T3
- Authority
- DK
- Denmark
- Prior art keywords
- arylalkyl
- alkyl
- formula
- hydrogen
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/620,811 US5110815A (en) | 1990-12-03 | 1990-12-03 | 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0489379T3 true DK0489379T3 (da) | 1999-04-19 |
Family
ID=24487491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91120652T DK0489379T3 (da) | 1990-12-03 | 1991-12-02 | 5-Amino-5,6,7,8-tetrahydroquinoliner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendels |
Country Status (17)
Country | Link |
---|---|
US (2) | US5110815A (de) |
EP (1) | EP0489379B1 (de) |
JP (1) | JP3090514B2 (de) |
KR (1) | KR100235506B1 (de) |
AT (1) | ATE168371T1 (de) |
AU (1) | AU639875B2 (de) |
CA (1) | CA2056793C (de) |
DE (1) | DE69129790T2 (de) |
DK (1) | DK0489379T3 (de) |
ES (1) | ES2119752T3 (de) |
FI (1) | FI915653A (de) |
IE (1) | IE914183A1 (de) |
NO (1) | NO914734L (de) |
NZ (1) | NZ240803A (de) |
PT (1) | PT99674B (de) |
TW (1) | TW211003B (de) |
ZA (1) | ZA919480B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL112568A0 (en) * | 1994-02-10 | 1995-05-26 | Wyeth John & Brother Ltd | Substituted quinolines, their preparation and pharmaceutical compositions containing them |
IL112567A (en) * | 1994-02-10 | 2000-02-29 | Wyeth John & Brother Ltd | Substituted quinolines their preparation and pharmaceutical compositions containing them |
IL112566A (en) * | 1994-02-10 | 2000-10-31 | Wyeth John & Brother Ltd | Substituted quinolinones and pharmaceutical compositions containing them |
KR0158065B1 (ko) * | 1995-05-29 | 1998-12-01 | 스기야마 가즈히코 | 반도체 집적회로장치 및 그 제조방법 |
KR100648869B1 (ko) | 1998-09-30 | 2007-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 방광 배출력 개선제 |
TWI301760B (en) * | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4789678A (en) * | 1986-08-25 | 1988-12-06 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds |
US4942168A (en) * | 1987-07-13 | 1990-07-17 | Hoechst-Roussel Pharmaceuticals Inc. | Hydroxyquinoline amines, and method of enhancing memory in mammals |
EP0361489A3 (de) * | 1988-09-30 | 1991-06-12 | Chugai Seiyaku Kabushiki Kaisha | 3,4-Diaminochinolin- und Pyridinverbindungen |
JPH0322011A (ja) * | 1989-06-19 | 1991-01-30 | Nec Corp | キーボード入力データ処理方式 |
-
1990
- 1990-12-03 US US07/620,811 patent/US5110815A/en not_active Expired - Lifetime
-
1991
- 1991-11-22 TW TW080109151A patent/TW211003B/zh active
- 1991-11-29 NZ NZ24080391A patent/NZ240803A/en unknown
- 1991-11-29 FI FI915653A patent/FI915653A/fi unknown
- 1991-12-02 ZA ZA919480A patent/ZA919480B/xx unknown
- 1991-12-02 DE DE69129790T patent/DE69129790T2/de not_active Expired - Fee Related
- 1991-12-02 ES ES91120652T patent/ES2119752T3/es not_active Expired - Lifetime
- 1991-12-02 AU AU88352/91A patent/AU639875B2/en not_active Expired - Fee Related
- 1991-12-02 EP EP91120652A patent/EP0489379B1/de not_active Expired - Lifetime
- 1991-12-02 CA CA002056793A patent/CA2056793C/en not_active Expired - Fee Related
- 1991-12-02 JP JP03317805A patent/JP3090514B2/ja not_active Expired - Fee Related
- 1991-12-02 NO NO91914734A patent/NO914734L/no unknown
- 1991-12-02 IE IE418391A patent/IE914183A1/en not_active IP Right Cessation
- 1991-12-02 AT AT91120652T patent/ATE168371T1/de not_active IP Right Cessation
- 1991-12-02 DK DK91120652T patent/DK0489379T3/da active
- 1991-12-03 KR KR1019910022011A patent/KR100235506B1/ko not_active IP Right Cessation
- 1991-12-03 PT PT99674A patent/PT99674B/pt not_active IP Right Cessation
-
1993
- 1993-03-19 US US08/035,335 patent/US5310914A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO914734L (no) | 1992-06-04 |
US5310914A (en) | 1994-05-10 |
FI915653A (fi) | 1992-06-04 |
CA2056793C (en) | 2003-03-11 |
AU8835291A (en) | 1992-06-04 |
KR100235506B1 (ko) | 1999-12-15 |
FI915653A0 (fi) | 1991-11-29 |
JPH04290872A (ja) | 1992-10-15 |
NO914734D0 (no) | 1991-12-02 |
JP3090514B2 (ja) | 2000-09-25 |
CA2056793A1 (en) | 1992-06-04 |
ES2119752T3 (es) | 1998-10-16 |
EP0489379B1 (de) | 1998-07-15 |
DE69129790T2 (de) | 1999-05-06 |
NZ240803A (en) | 1994-07-26 |
KR920012036A (ko) | 1992-07-25 |
TW211003B (de) | 1993-08-11 |
PT99674B (pt) | 1999-05-31 |
EP0489379A1 (de) | 1992-06-10 |
DE69129790D1 (de) | 1998-08-20 |
US5110815A (en) | 1992-05-05 |
ATE168371T1 (de) | 1998-08-15 |
ZA919480B (en) | 1992-08-26 |
PT99674A (pt) | 1992-10-30 |
AU639875B2 (en) | 1993-08-05 |
IE914183A1 (en) | 1992-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0256503A3 (en) | Pyridinecarboxamide derivatives and their use as fungicide | |
FI901447A0 (fi) | Menetelmä farmakologisesti aktiivisten 8-substituoitujen ksantiinijohdannaisten valmistamiseksi | |
DK0437030T3 (da) | Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk | |
DK0474243T3 (da) | 1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf | |
PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
NO892295L (no) | Fremgangsmaate for fremstilling av nye cefemforbindelser. | |
ES2055235T3 (es) | Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation. | |
DE69001111D1 (de) | Antikrebs-zusammensetzung. | |
DK0489379T3 (da) | 5-Amino-5,6,7,8-tetrahydroquinoliner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendels | |
HUT50337A (en) | Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds | |
DE69629341D1 (de) | Pyrrolocarbazolderivate | |
FI935798A0 (fi) | Alkylsubstituerade heterocykliska foereningar | |
DK0420224T3 (da) | Anthihepatopatisk middel | |
ATE105565T1 (de) | Pradimicinderivate. | |
FI883507A (fi) | Naftotiazepinderivat och deras framstaellning. | |
ATE79259T1 (de) | Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung. | |
MY101746A (en) | 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof. |